Shares of Cypress Semiconductor (NASDAQ:CY) were the target of a significant increase in short interest during the month of December. As of December 15th, there was short interest totalling 20,925,007 shares, an increase of 97.3% from the November 28th total of 10,605,527 shares, Stock Ratings Network reports. On Friday shares of Cypress Semiconductor Corporation (NASDAQ:CY) closed at $15.04. Company’s sales growth for last 5 years was -1.10% and EPS growth for next 5 years is recorded as 13.45%.
Marvel Technology Group Ltd. (NASDAQ: MRVL) said it has introduced a new 802.11ac Wave-2 4×4 processor that increases bandwidth, achieves high speed, secure and reliable access points, and smart gateways. Marvell Technology Group Ltd. (NASDAQ:MRVL) in last trading activity increased 0.06% to close at $16.03. Company weekly performance is 10.40% while its quarterly performance stands at 22.55%. Marvell Technology Group Ltd. (NASDAQ:MRVL) is -2.52% away from its 52 week high.
Agios Pharmaceuticals Inc (NASDAQ:AGIO),The Chief Scientific Officer of Agios Pharmaceuticals Inc, Biller Scott sold 4,500 shares at $110.08 on January 2, 2015. The Insider selling transaction had a total value worth of $495,360. On last trading day Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) increased 5.04% to close at $128.12. Its volatility for the week is 5.47% while volatility for the month is 6.17%. Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) monthly performance is 15.88%.
Fred’s Inc (NASDAQ:FRED), an operator of discount general merchandise stores, announced that comparable store sales for the month of December decreased 1.4 percent on top of an increase of 1.4 percent last year. However, sales for the month increased 1 percent to $210.7 million from $209.1 million a year ago. Fred’s, Inc. (NASDAQ:FRED) has 0.70% insider ownership while its institutional ownership stands at 90.30%. In last trading activity company’s stock closed at $16.70.
Intercept Pharmaceuticals (NASDAQ:ICPT) CMO David Shapiro sold 664 shares of the company’s stock in a transaction dated Monday, January 5th. The shares were sold at an average price of $172.63, for a total value of $114,626.32. Following the transaction, the chief marketing officer now directly owns 14,648 shares of the company’s stock, valued at approximately $2,528,684. On last trading day Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) fell -0.69% to close at $150.00. Its volatility for the week is 9.66% while volatility for the month is 6.44%. Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) monthly performance is 2.72%.